-
Loading metrics
Open Access
Peer-reviewed
Research Article
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
-
Lijun Gu ,
Contributed equally to this work with: Lijun Gu, Yang Han
Affiliations China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China, Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan
⨯ -
Yang Han ,
Contributed equally to this work with: Lijun Gu, Yang Han
Affiliation Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
⨯ -
Yijia Li,
Affiliation Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
⨯ -
Ting Zhu,
Affiliation Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
⨯ -
Xiaojing Song,
Affiliation Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
⨯ -
Ying Huang,
Affiliation China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China
⨯ -
Feifei Yang,
Affiliation China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China
⨯ -
Shuo Guan,
Affiliation China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China
⨯ -
Jing Xie,
Affiliation Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
⨯ -
Jin Gohda,
Affiliations China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China, Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan
⨯ -
Noriaki Hosoya,
Affiliation Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan
⨯ -
Ai Kawana-Tachikawa,
Affiliation Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
⨯ -
Wenjun Liu,
Affiliations China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China
⨯ -
George Fu Gao,
Affiliation CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China
⨯ -
Aikichi Iwamoto,
Affiliations Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
⨯ -
Taisheng Li ,
* E-mail: imoakat@ims.u-tokyo.ac.jp (TI); litsh@263.net (TL)
Affiliation Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China
⨯ - [ ... ],
-
Takaomi Ishida
* E-mail: imoakat@ims.u-tokyo.ac.jp (TI); litsh@263.net (TL)
Affiliations China-Japan Joint Laboratory of Molecular Immunology & Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China, Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan
⨯ - [ view all ]
- [ view less ]
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
- Lijun Gu,
- Yang Han,
- Yijia Li,
- Ting Zhu,
- Xiaojing Song,
- Ying Huang,
- Feifei Yang,
- Shuo Guan,
- Jing Xie,
- Jin Gohda
- Published: August 19, 2015
- https://doi.org/10.1371/journal.pone.0134539